ASKA Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own ASKA Pharmaceutical Co. Ltd.
Fidelity Japan Japanese Growth Equity Mother Fund
522,899
1.71%
-123,000
0.14%
11/30/2017
Government Pension Fund - Global (The)
421,400
1.38%
19,100
0%
12/31/2017
Nomura Asset TOPIX ETF Fund (1306)
359,600
1.18%
5,700
0.01%
07/31/2018
Vanguard Total International Stock Index Fund
287,296
0.94%
0
0%
07/31/2018
DFA International Small Cap Value Portfolio
235,600
0.77%
-20,400
0.02%
04/30/2018
Daiwa Asset Value Equity Open Mother Fund
213,299
0.7%
213,299
0.22%
06/25/2018
Daiwa Asset TOPIX Listed ETF (1305)
176,500
0.57%
1,400
0.01%
07/31/2018
DFA Japanese Small Company Series
164,300
0.54%
0
0.05%
01/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
162,000
0.53%
0
0.01%
08/20/2018
Goldman Sachs International Small Cap Insights Fund
160,000
0.52%
0
0.07%
01/31/2018
| Address |
2-5-1 Shibaura
Tokyo Tokyo 108
Japan
|
|
Employees
|
- |
| Website |
http://www.aska-pharma.co.jp |
| Updated |
07/08/2019 |
| ASKA Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceuticals,veterinary medicines,quasi-drugs,foods,and medical devices. It operates through the following business division: Research and Development. The Research and Development division provides new medicine in R&D system with a balanced combination of cutting-edge pharmaceutical technology and a long experience, to grow and expand persistently as a medium R&D company focusing on a specialized field. |
